Tim A Kanters
Affiliation: Erasmus University
Country: The Netherlands
- The impact of informal care for patients with Pompe disease: an application of the CarerQol instrumentTim A Kanters
Institute for Medical Technology Assessment, Department of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, P O Box 1738, 3000 DR Rotterdam, The Netherlands Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Dr Molewaterplein 60, 3015 GJ, Rotterdam, The Netherlands Electronic address
Mol Genet Metab 110:281-6. 2013..Patients with Pompe disease, a rare progressive neuromuscular disorder, receive a considerable amount of informal care. In this study, we examined the impact of providing informal care to patients with Pompe disease...
- Systematic review of available evidence on 11 high-priced inpatient orphan drugsTim A Kanters
Institute for Medical Technology Assessment, Department of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, PO Box 1738, 3000DR Rotterdam, The Netherlands
Orphanet J Rare Dis 8:124. 2013..This study systematically reviews the available evidence on clinical effectiveness, cost-effectiveness and budget impact for orphan drugs...
- A new prevention paradox: the trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurersTim A Kanters
Institute of Health Policy and Management, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
Soc Sci Med 76:150-8. 2013..This highlights a new prevention paradox: improving the level playing field for health insurers will inevitably limit their incentives for promoting the health of their clients...
- Burden of illness of Pompe disease in patients only receiving supportive careTim A Kanters
Department of Health Policy and Management, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
J Inherit Metab Dis 34:1045-52. 2011....